| Literature DB >> 263292 |
K S Kendler, R E Weitzman, R T Rubin.
Abstract
Haloperidol, a central nervous system dopamine blocker, was given im to seven normal volunteers at a dose level (1.0 mg) known to have central nervous system effects. Plasma PRL levels rose sharply in response to haloperidol, but plasma arginine vasopressin levels did not change significantly. These data do not support the hypothesis of a prominent dopamine neurotransmitter regulation of arginine vasopressin secretion.Entities:
Mesh:
Substances:
Year: 1978 PMID: 263292 DOI: 10.1210/jcem-47-1-204
Source DB: PubMed Journal: J Clin Endocrinol Metab ISSN: 0021-972X Impact factor: 5.958